018840575

XOANACYL

---

February 23, 2023

Trademark Summary

The trademark application XOANACYL was filed by Averoa, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on March 2, 2023, and it was registered by office on June 9, 2023 without any oppositions.

The application was filed in French (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations for the treatment of kidney diseases
  2. Pharmaceuticals
  3. Pharmaceutical preparations
  4. Chemico-pharmaceutical preparations
  5. Pharmaceutical compositions
  6. Phosphates for pharmaceutical purposes
  7. Cachets for pharmaceutical purposes
  8. Pharmaceutical preparations and substances
  9. Chemical preparations for pharmaceutical purposes
  10. Chemicals for pharmaceutical use
  11. Pharmaceutical preparations for use in hematology
  12. Pharmaceutical agents affecting metabolism
  13. Pharmaceuticals and natural remedies
  14. Pharmaceutical preparations for use in urology
  15. Pharmaceutical preparations for human use
  16. Ocular pharmaceuticals
  17. Synthetic peptides for pharmaceutical purposes
  18. Diagnostic agents for pharmaceutical use
  19. Pharmaceutical solutions used in dialysis
  20. Amino acid preparations for pharmaceutical use
  21. Pharmaceutical preparations for use in tissue transplantation
  22. Pharmaceutical preparations for the prevention of diabetes
  23. Tissue-regenerative pharmaceutical preparations
  24. Pharmaceutical preparations and substances for use in urology
  25. Pharmaceutical preparations and substances for use in the field of anesthesia
  26. Pharmaceutical preparations and substances with analgesic properties
  27. Pharmaceutical preparations for peripheral nervous system
  28. Pharmaceutical preparations for treating hypoglycemia
  29. Pharmaceutical preparations for the prevention of inflammatory diseases
  30. Pharmaceutical preparations for the treatment of inflammatory diseases
  31. Pharmaceutical preparations for the treatment of kidney disorders
  32. Pharmaceutical preparations for use in organ transplantation
  33. Pharmaceutical preparations for treating metabolic disorders
  34. Pharmaceutical preparations for the prevention of inflammatory disorders
  35. Pharmaceutical preparations for the treatment of inflammatory disorders
  36. Pharmaceutical preparations for the treatment of hormonal disorders
  37. Pharmaceutical preparations for treating chemical imbalances
  38. Pharmaceutical preparations for the treatment of bone fractures
  39. Filled syringes for medical purposes [containing pharmaceuticals]
  40. Pharmaceutical preparations for the treatment of bone diseases
  41. Pharmaceutical products for the treatment of bone diseases
  42. Pharmaceutical preparations for the treatment of digestive diseases
  43. Pharmaceutical preparations and substances with anti-inflammatory properties
  44. Pharmaceutical preparations for the prevention of autoimmune disorders
  45. Pharmaceutical preparations for treating gastrointestinal disorders
  46. Pharmaceutical preparations for the prevention of autoimmune diseases
  47. Pharmaceutical preparations for the treatment of autoimmune disorders
  48. Pharmaceutical preparations for treating skeletal diseases
  49. Pharmaceutical preparations for the treatment of cardiovascular disease
  50. Pharmaceutical preparations for the treatment of musculo-skeletal disorders
  51. Pharmaceutical preparations for the treatment of autoimmune diseases
  52. Pharmaceutical preparations for the prevention of disorders of the metabolic system
  53. Pharmaceutical preparations for treating digestive system disorders
  54. Pharmaceutical preparations for the prevention of diseases of the metabolic system
  55. Pharmaceutical preparations for the treatment of diseases of the metabolic system
  56. Pharmaceutical preparations for the treatment of diseases of the endocrine system
  57. Pharmaceutical preparations for the treatment of disorders of the metabolic system
  58. Pharmaceutical preparations for the prevention of disorders of the endocrine system
  59. Pharmaceutical preparations for the treatment of disorders of the endocrine system
  60. Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
  61. Pharmaceutical preparations for the treatment of heart rhythm disorders
  62. Pharmaceutical preparations for the treatment of diseases of the genitourinary system
  63. Pharmaceutical preparations for the prevention of diseases of the genitourinary system
  64. Pharmaceutical preparations for the treatment of disorders of the genitourinary system
  65. Pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system
  66. Pharmaceutical preparations for the prevention of disorders of the genitourinary system
  67. Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases
  68. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
  69. Injectable pharmaceuticals
  70. Diuretic pharmaceutical preparations
  71. Pharmaceutical creams
  72. Syrups for pharmaceutical purposes
  73. Pharmaceutical preparations for inhalers
  74. Ergot for pharmaceutical purposes
  75. Pharmaceutical preparations for use in ophthalmology
  76. Pharmaceutical preparations for use in dermatology
  77. Antiarrhythmic agents
  78. Pharmaceutical products for ophthalmological use
  79. Pharmaceutical preparations for veterinary use
  80. Plant extracts for pharmaceutical purposes
  81. Pharmaceutical agents affecting digestive organs
  82. Tryptophane preparations
  83. Pharmaceutical preparations for immunity adjustment
  84. Pharmaceutical preparations for the prevention of ocular disorders
  85. Pharmaceutical preparations for the prevention of ocular diseases
  86. Pharmaceutical preparations for treating arthritis
  87. Pharmaceutical preparations for treating rheumatological diseases
  88. Pharmaceutical preparations for the prevention of osteoporosis
  89. Pharmaceutical preparations for the treatment of osteoporosis
  90. Diagnostic preparations for medical purposes
  91. Clinical diagnostic reagents
  92. Diagnostic preparations and materials
  93. Medical diagnostic test strips
  94. Diagnostic substances for medical use
  95. Diagnostic agents for medical use
  96. In vitro diagnostic preparations for medical use.
• The mark was filed in class 10 with following description of goods:
  
  1. Artificial kidneys
  2. Medical apparatus for renal dialysis
  3. Injection device for pharmaceuticals
  4. Pharmaceutical instruments
  5. Tools for medical diagnostics
  6. Diagnostic apparatus for medical purposes
  7. Medical diagnostic apparatus for medical purposes
  8. Testing instruments for medical diagnostic purposes
  9. Diagnostic measuring apparatus for medical use
  10. Ultrasonic diagnostic instruments for medical use.